Individuals without severe gastrointestinal disease , active pancreatitis, or other contraindications relevant to incretin-based therapies
Medication delivered to your home, with continuous supply and no hidden costs
People using semaglutide with insulin or a sulfonylurea should follow their diabetes care plan when headache occurs with sweating, shaking, blurred vision, weakness, confusion, or unusual behavior
Its important to take the right dosage of semaglutide and take it consistently
GLP-1 RA Addition to Background Sulfonylurea Therapy Similar to the discussion above about background insulin, it is prudent in many cases to hold or reduce the dose of background sulfonylurea therapy (an initial 50% dose reduction is reasonable in many patients) when starting a GLP-1 RA
Cholesterol-Lowering Drugs 4